Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3
Open Access
- 9 December 2015
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 4, e10766
Abstract
Integrins are heterodimeric cell surface adhesion and signaling receptors that are essential for metazoan existence. Some integrins contain an I-domain that is a major ligand binding site. The ligands preferentially engage the active forms of the integrins and trigger signaling cascades that alter numerous cell functions. Here we found that the adenylate cyclase toxin (CyaA), a key virulence factor of the whooping cough agent Bordetella pertussis, preferentially binds an inactive form of the integrin complement receptor 3 (CR3), using a site outside of its I-domain. CyaA binding did not trigger downstream signaling of CR3 in human monocytes and CyaA-catalyzed elevation of cAMP effectively blocked CR3 signaling initiated by a natural ligand. This unprecedented type of integrin-ligand interaction distinguishes CyaA from all other known ligands of the I-domain-containing integrins and provides a mechanistic insight into the previously observed central role of CyaA in the pathogenesis of B. pertussis.Keywords
Funding Information
- Grantová Agentura České Republiky (GAP302/11/0580)
- Institutional Research Project of the Institute of Microbiology (RVO 61388971)
- Project of the Charles University in Prague (UNCE204025/2012)
- Grantová Agentura České Republiky (GA15-11851S)
- ERDF (BIOCEV CZ.1.05/1.1.00/02.0109)
- Institutional Research Project of the Institute of Biotechnology (RVO 86652036)
- Grantová Agentura České Republiky (GA13-14547S)
This publication has 86 references indexed in Scilit:
- Quantification of the Adenylate Cyclase Toxin of Bordetella pertussisIn Vitroand during Respiratory InfectionInfection and Immunity, 2013
- The Bordetella pertussis adenylate cyclase toxin binds to T cells via LFA-1 and induces its disengagement from the immune synapseJournal of Experimental Medicine, 2011
- The tail of integrin activationTrends in Biochemical Sciences, 2011
- I-TASSER: a unified platform for automated protein structure and function predictionNature Protocols, 2010
- Structure of an integrin with an αI domain, complement receptor type 4The EMBO Journal, 2009
- Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infectionBlood, 2009
- Accelerating molecular dynamic simulation on graphics processing unitsJournal of Computational Chemistry, 2009
- RTX cytotoxins recognize β 2 integrin receptors through N-linked oligosaccharidesProceedings of the National Academy of Sciences, 2008
- Bordetella pertussisInhibition of Interleukin-12 (IL-12) p70 in Human Monocyte-Derived Dendritic Cells Blocks IL-12 p35 through Adenylate Cyclase Toxin-Dependent Cyclic AMP InductionInfection and Immunity, 2006
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005